Esqueci minha senha

XIII SBBN Congress and 20th IUPAB Congress 2021

Mapa não está disponível

Data / Hora
04/10/2021 - 08/10/2021
All Day


Since 2017, SBBN is affiliated to the International Union for Pure and Applied Biophysics ( In 2020, October 27 to 29, we are promoting the XIII SBBN Congress in the same venue and in parallel with the 20th International IUPAB Congress, to held in October, 26 to 30.

The XIII SBBN Congress whole program will be composed of Conferences, Symposia, Courses, Oral communications and Poster Sessions. All participants may attend in both (IUPAB and SBBN) meetings with only one inscription. Fellowships may be offered for the SBBN affiliated students with abstracts selected by the Scientific Committee.

Topics for the SBBN Congress:
Biology Systems and Biomedical Applications; Challenges in preclinical and clinical studies; Drug design and delivery modelling; radiopharmaceuticals development; Images and signaling processing; Molecular and cell imaging; PET and SPECT imaging; Nanomaterials, nanobiotechnology and nanotoxicity; Optical techniques for diagnosis and therapy; Radiobiology (including environmental aspects), Genetics and Radiotherapy; Radioisotopes production in cyclotron and nuclear reactors; Science Education.
Topics (general) for the 20th IUPAB Congress:
Ageing and Cell Death; Biomaterials; Biomedical Applications; Biomembranes; Drug design and delivery; Energy and Metabolism; Evolution and Emerging Behavior; Molecular and Cell Imaging; Molecular Machinery; Molecular Mechanisms of Disease; Nucleic acids structure and functions; Optogenetics and neural system; Protein Folding Misfolding and Unfolding; Protein Structure Dynamics and Functions; Receptors and Signalling; Redox Process; Science Education; Stem Cell and Cell Therapy; Synthetic Biology; Systems Biology.

SBBN Preliminary program – Symposia

Biomaterials and molecular imaging techniques
Chairs: Marcelo Mamede (Medical School, Minas Gerais Federal University, Belo Horizonte, Brazil) and Priscilla Pujatti (National Cancer Institute, Rio de Janeiro, Brazil)
• Theranostic radiopharmaceuticals (Suzane Lapi, Department of Radiology, Cyclotron Facility Director, University of Alabama at Birmingham, Alabama, USA)
• Total-Body Radiotracer Pharmacokinetics and Molecular Imaging (Simon R. Cherry, Department of Biomedical Engineering and Department of Radiology, University of California, Davis, USA)
• Molecular imaging for research in Oncology (Carlos Buchpiguel, Professor and Director of the Nuclear Medicine Center, Sao Paulo University Medical School, Brazil)

Molecular Imaging in Neurosciences
Chairs: Luciana Malavolta (Santa Casa Medical School, São Paulo, Brazil) and Valbert Cardoso (Pharmacy School, Minas Gerais Federal University, Belo Horizonte, Brazil)
• New trends in PET radiopharmaceuticals for neurodegenerative diseases (Eduardo Savio, Head of the Radiopharmacy, Research and Development Department, Uruguayan Centre for Molecular Imaging, Montevideo, Uruguay)
• Pericytes and the intersection between tissue regeneration and pathology (Alexander Birbrair, Professor at the Pathology Department of the Biological Sciences Institute of the Federal University of Minas Gerais, Belo Horizonte, Brazil)
• PET/CT/MRI fusion images showing cranial and peripheral nerve involvement in neurolymphomatosis (Lauro Wichert-Ana, Professor and Coordinator of the Nuclear Medicine Division, Ribeirão Preto Medical School, University of São Paulo, Brazil)

Radiobiology and Radiotherapy
Chairs: Ademir Amaral (Pernambuco Federal University, Recife, Brazil) and Divanizia N. Souza (Sergipe Federal University, Aracaju, Brazil)
• Radiation interaction and response from cells and tissues: radiation risk models versus individualized medicine (Dunstana Melo, Melohill Tech., Washington, USA)
• Dose fractionation in Radiotherapy patients (Helena Segreto, EPM- UNIFESP, Brazilian Society on Radiotherapy-SBRT, São Paulo, Brazil)
• Abscopal effect of Radiotherapy: clinical and radiobiological aspects – speaker to be confirmed

Nuclear accidents and the environmental impact to the Health
Chairs: Edson Andrade (Nuclear Engineering Institute, Rio de Janeiro, Brazil) and Marcos do Amaral (Brazilian Society on Radiation Protection, Brazil)
• Nuclear accidents and decision making in the perspective of environmental radiological releases (Matthew Healy, Cranfield University, UK)
• New trends in Biodosimetry – speaker to be confirmed

Challenges for clinical studies in Brazil and the regulatory framework (120 min)
Chair: Silvia Velasques (SBBN, Rio de Janeiro, Brazil)
• Clinical studies design, patients sampling and ethics committees: Brazilian experiences (Juliano Cerci, Brazilian Society on Nuclear Medicine-SBMN, Curitiba, Brazil)
• Education and individual capabilities in the multidisciplinary teams for developing clinical studies (Ana Maria Marques da Silva, PUC-RS, Porto Alegre, Brazil)
• The reference hospitals, the equipment state-of-the art and the regional inequities (Jorge Wagner E. da Silva, National Cancer Institute, Health Ministry, Rio de Janeiro, Brazil)